Please login to the form below

Not currently logged in
Email:
Password:

Huntsworth Health restructures worldwide

Huntsworth Health has restructured its worldwide operations to better meet the changing needs of its clients.

Huntsworth Health has restructured its worldwide operations to better meet the changing needs of its clients. The company has realigned, and in some cases rebranded, its agencies establishing four distinct areas if expertise – medical communications, brand experience, public relations and consulting and analytics.

Newly appointed CEO of Huntsworth Health, Neil Matheson, said: "As a global family of best-in-class healthcare agencies, our new structure provides a solid platform for future organic growth while also providing a stable landing pad for strategic acquisitions."

Matheson also said the realignment will result in dedicated account teams in Europe and the US, which will provide state-of-the-art services to clients at a global, regional and local level.

Huntsworth's current medical communications teams will be rebranded as ApotheCom and will work in unison with the ApotheCom teams on both the east and west coasts of the US. The European brand communication teams combined with Dorland Global Health Communications in North America will form nitrogen, and Huntworth's European digital team will become nitrogen interactive. All of Huntsworth's public relations team, which consists of the current Tonic team and Dorland Global PR (based in the US), will operate under the brand Tonic Life Communications. The company's consulting and analytics offering will continue to operate as Brand Health International.

"We want people to recognise the Huntsworth Health logo as synonymous with quality while also recognising our global brands as centres of excellence in their specific area of global healthcare communications," said Sandy Royden, CEO of Huntsworth Health Europe.

13th October 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics